"Platform" technologies are always valued higher than single indication drug candidates.
This is what will bring Pharma to the table imo.
The other pertinent point, Pharma doesn't usually partner with microcaps - they buy them!
Dr. Campbell is a smart operator - I'm loving the sector commentary and reference to Pharma transactions.
.
Ann: Shareholder Newsletter - June 2021, page-11
Add PAB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $14.40M | |||
| Open | High | Low | Value | Volume |
| 0.7¢ | 0.7¢ | 0.6¢ | $27.32K | 4.098M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 14 | 4353235 | 0.6¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 643561 | 4 |
View Market Depth
| Last trade - 15.51pm 26/06/2024 (20 minute delay) ? |
| PAB (ASX) Chart |